๐
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
COVID-19 Vaccine (ChAdOx1-S [recombinant])
COVID-19 virus infection
๐ซ Withdrawn
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Vaxzevria is indicated for active immunisation to prevent COVID 19 caused by SARS CoV 2, in individuals 18 years of age and older. The use of this vaccine should be in accordance with official recommendations.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria